Cargando…
Characteristics of adults with type 1 diabetes and treatment-resistant problematic hypoglycaemia: a baseline analysis from the HARPdoc RCT
AIMS/HYPOTHESIS: Problematic hypoglycaemia still complicates insulin therapy for some with type 1 diabetes. This study describes baseline emotional, cognitive and behavioural characteristics in participants in the HARPdoc trial, which evaluates a novel intervention for treatment-resistant problemati...
Autores principales: | Jacob, Peter, Potts, Laura, Maclean, Rory H., de Zoysa, Nicole, Rogers, Helen, Gonder-Frederick, Linda, Smith, Emma L., Kariyawasam, Dulmini, Brooks, Augustin, Heller, Simon, Toschi, Elena, Kendall, Mike, Bakolis, Ioannis, Choudhary, Pratik, Goldsmith, Kimberley, Amiel, Stephanie A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943518/ https://www.ncbi.nlm.nih.gov/pubmed/35325258 http://dx.doi.org/10.1007/s00125-022-05679-5 |
Ejemplares similares
-
A parallel randomised controlled trial of the Hypoglycaemia Awareness Restoration Programme for adults with type 1 diabetes and problematic hypoglycaemia despite optimised self-care (HARPdoc)
por: Amiel, Stephanie A., et al.
Publicado: (2022) -
Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc): protocol for a group randomised controlled trial of a novel intervention addressing cognitions
por: Amiel, Stephanie A, et al.
Publicado: (2019) -
Hypoglycemia Subtypes in Type 1 Diabetes: An Exploration of the Hypoglycemia Fear Survey-II
por: Maclean, Rory H., et al.
Publicado: (2022) -
Hypoglycaemia in type 1 diabetes: technological treatments, their limitations and the place of psychology
por: Choudhary, Pratik, et al.
Publicado: (2018) -
Changes in attitudes to awareness of hypoglycaemia during a hypoglycaemia awareness restoration programme are associated with avoidance of further severe hypoglycaemia episodes within 24 months: the A2A in HypoCOMPaSS study
por: Sepúlveda, Eduardo, et al.
Publicado: (2022)